Mutations in fibrillin-1 give rise to a spectrum of disorders associated with dysregulated TGFβ signalling termed fibrillinopathies, the most common of which is Marfan syndrome (MFS) [4]. This evidence concerns the gene FBN1 and Marfan syndrome.